Knollwood Investment Advisory LLC boosted its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 3.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,331 shares of the semiconductor company's stock after acquiring an additional 450 shares during the quarter. Knollwood Investment Advisory LLC's holdings in Synopsys were worth $6,146,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SNPS. GAMMA Investing LLC lifted its holdings in Synopsys by 54,286.0% during the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company's stock valued at $513,116,000 after purchasing an additional 1,194,292 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in Synopsys by 21.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company's stock worth $2,864,933,000 after buying an additional 1,045,326 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Synopsys during the first quarter worth approximately $341,480,000. Pictet Asset Management Holding SA raised its stake in shares of Synopsys by 38.3% in the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock valued at $1,043,518,000 after acquiring an additional 673,837 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of Synopsys by 26.2% in the fourth quarter. Ameriprise Financial Inc. now owns 1,888,181 shares of the semiconductor company's stock valued at $916,441,000 after acquiring an additional 391,681 shares during the last quarter. Institutional investors own 85.47% of the company's stock.
Synopsys Trading Up 1.4%
Shares of SNPS stock traded up $8.35 on Friday, reaching $606.52. 863,153 shares of the stock were exchanged, compared to its average volume of 1,313,433. The company has a debt-to-equity ratio of 1.01, a current ratio of 7.02 and a quick ratio of 6.85. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The stock has a market cap of $94.11 billion, a PE ratio of 43.79, a P/E/G ratio of 3.93 and a beta of 1.15. The stock has a 50 day moving average price of $570.29 and a 200 day moving average price of $500.95.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, topping analysts' consensus estimates of $3.40 by $0.27. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.60 billion. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The company's revenue was up 10.3% on a year-over-year basis. During the same period last year, the company earned $3.00 earnings per share. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. Equities research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 7,310 shares of the stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $485.72, for a total value of $3,550,613.20. Following the transaction, the chief financial officer directly owned 15,291 shares in the company, valued at $7,427,144.52. This represents a 32.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the completion of the transaction, the chief executive officer directly owned 71,589 shares in the company, valued at approximately $32,782,750.77. The trade was a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,686 shares of company stock valued at $13,001,048 over the last ninety days. Insiders own 0.62% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on the company. Rosenblatt Securities increased their price target on Synopsys from $625.00 to $650.00 and gave the stock a "buy" rating in a research report on Friday, July 25th. Stifel Nicolaus set a $550.00 price objective on Synopsys in a research note on Monday, April 28th. Morgan Stanley reaffirmed an "overweight" rating and issued a $715.00 price target (up from $540.00) on shares of Synopsys in a report on Monday, August 11th. Needham & Company LLC reiterated a "buy" rating and set a $660.00 price target (up previously from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. Finally, The Goldman Sachs Group started coverage on shares of Synopsys in a report on Thursday, July 10th. They set a "buy" rating and a $620.00 price objective on the stock. Twelve analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $626.79.
View Our Latest Report on SNPS
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report